CEO’s Letter to Shareholders

Link to Article

Scientific Leaders Agree on Promise of Enochian BioSciences

Link to Article

Groundbreaking Science that transforms the life of patients

One audacious mission to use groundbreaking science for cures and effective prevention of infectious diseases and cancer.

call to action

Enochian / Eno-key-in

Enochian BioSciences is a biopharmaceutical company dedicated to identifying, developing, manufacturing, and commercializing gene-modified cell therapy. Our gene-modified cell therapy platform can be applied to multiple indications including HIV/AIDS and Oncology.

Our Objectives



HIV Preventative Vaccine and Cures

HBV Treatment or Cure

Cellular Immune-oncology Products

Focused for the prevention of relapse of metastatic colon cancer after resection and chemotherapy

Genetically-modified Dendritic Cell Platform for Treatment of Cancer

Why Do We Need a Cure and a Vaccine for HIV?


0 Living with HIV Worldwide in 2017

0 Infected with HIV Worldwide in 2017

0 AIDS Related Deaths Worldwide in 2017

0 Diagnosed with HIV in the U.S. in 2017

“I was attracted to Enochian by some of the most innovative scientific ideas I had seen in my more than 35 years as a Researcher. I have performed independent, pivotal laboratory and animal studies on the HIV, Hepatitis B and SARS-CoV-2 pipelines of Enochian BioSciences and have seen the very promising data for myself. Indeed, I have been an author on abstracts reviewed, accepted and presented at several important scientific conferences. I am enthusiastic about further collaborations with the Company.”

Dr. Philippe Gallay, Professor of Immunology and Microbiology, Scripps Research